Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
127,152,297
-
Share change
-
-895,681
-
Total reported value
-
$27,396,393,746
-
Put/Call ratio
-
101%
-
Price per share
-
$215.63
-
Number of holders
-
923
-
Value change
-
-$328,447,788
-
Number of buys
-
376
-
Number of sells
-
488
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2024
As of 31 Mar 2024,
BIOGEN INC. - COM (BIIB) was held by
923 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,152,297 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., STATE STREET CORP, T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, VAN ECK ASSOCIATES CORP, and MORGAN STANLEY.
This page lists
932
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.